Oncotarget Field Research Journal

The ever increasing number of cancer cases and related complications around the world is sometimes linked to limited access to oncology information. In order to address this challenge, open access medical journals such as Oncotarget have been established as a way of increasing access to oncology information, research, and data. Impact Publishers are the official publishers of the Oncotarget weekly peer reviewed journal. The journal was published for the first time in 2010, and has since then been making significant contribution in improving access to oncology information. Andrei V. Gudkov and Mikhail Blagosklonny are the editors-in-chief.

Through insightful peer review, the journal has been able to maximize oncology research impact. Authors get a perfect platform to expand the scope of impact of their research findings when they present their work to Oncotarget. The journal has become popular within a very short period of time because of its multiple, constructive, punctual, and insightful peer review. In addition, the journal publishes papers on other topics apart from oncology, because of its popularity. Some of the other topics that are published in the weekly peer-reviewed journal include Pharmacology, Cell Biology, Metabolism, Cardiology, Endocrinology, Neuroscience, Autophagy and Cell Death, and Pathology beyond Oncology.

The free-access multidisciplinary journal publishes papers on a weekly basis on its online platform. Apart from the online publications, one can get printed versions upon request. The journal’s mission is to make scientific results readily available within the shortest time possible. The insightful review is able to maximize the impact of research, and make it possible for very critical discoveries to be shared as soon as possible.

Moreover, the border between different specialties has been eliminated since the introduction of this journal. Biomedical science has many different fields that have successfully been linked by Oncotarget.The best way to fight disease is through the application of clinical science discoveries and data, and Oncotarget plays a critical role in collecting and disseminating such information. The ultimate goal of medical research is to completely eliminate disease, and Oncotarget helps prominent scientists to contribute to this endeavor. The decision to introduce other sections beyond oncology subjects was prompted by the journal’s success.